— Know what they know.
Not Investment Advice

PYPD NASDAQ

PolyPid Ltd.
1W: -0.6% 1M: -2.1% 3M: -7.0% YTD: +19.3% 1Y: +54.0% 3Y: -37.1% 5Y: -97.9%
$5.19
-0.18 (-3.35%)
 
Weekly Expected Move ±5.8%
$5 $5 $5 $5 $6
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 43 · $99.0M mcap · 11M float · 1.68% daily turnover · Short 44% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$33M -17.6% ▼
Net Income
-$34M -17.7% ▼
EPS (Diluted)
$-2.09 +57.4% ▲
EBITDA
-$32M -20.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$1M$2M$0$0$0
Gross Profit-$1M-$2M$0$0$0
Gross Margin—————
R&D Expenses$30M$28M$16M$23M$24M
SG&A Expenses$12M$11M$7M$5M$9M
Operating Expenses$42M$37M$23M$28M$33M
Operating Income-$43M-$39M-$23M-$28M-$33M
Operating Margin—————
Interest Expense$0$1M$2M$2M$685K
Income Before Tax-$43M-$39M-$24M-$29M-$34M
Tax Expense$0$129K$69K$42K$5K
Net Income-$41M-$40M-$24M-$29M-$34M
Net Margin—————
EPS (Diluted)$-67.80$-61.20$-16.99$-4.91$-2.09
EBITDA-$41M-$36M-$21M-$26M-$32M
Shares Outstanding1M1M1M6M16M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms